The global Radiodermatitis market for the historical period 2017–2018 and forecast period 2019–2027, Rise in cancer incidence across globe, innovation leading to product offerings, growing partnerships and agreements amongst companies , collaboration between industry academia & industry-institutes, rising merger & acquisitions, entry of new players, and increase in access to health care are projected to drive the global Radiodermatitis Market .As per research, radiodermatitis likely to occur in more than 50% of the patients who underwent radiation therapy for cancer and it could rise up to 95% also.
According to the report, the global radiodermatitis market was valued at US$ 334.2 Mn in 2018 and is projected to expand at a CAGR of 3.3% from 2019 to 2027.
Get the sample copy of report@ https://qyresearchmedical.com/sample/111702
Rise in cancer incidence across globe and growing co-morbid conditions: Key Drivers
According to the WHO, the number of new cancer cases is expected to rise to 22 million by 2032, and 9.6 million deaths are estimated in the year 2018. As per International Agency for Research on Cancer (IARC), the global cancer burden increases with 18.1 million cases estimated new cases each year. In addition, the rate of certain types of cancers such as breast cancer and head and neck cancer is projected to escalate. This is attributable to faulty lifestyle factors such as obesity for breast cancer, and smoking for head and neck cancers. Moreover, the aforementioned cancers are treated with radiation at site. Hence, patients suffering from these cancers are more likely to develop radiation-induced dermatitis. Therefore, the overall spiral in cancer cases coupled with a surge in specific cancers due to faulty lifestyle is likely to propel the radiodermatitis market. As per WHO, statistics, growing tobacco consumption and alcohol abuse accounts for 40% of the cancer burden across European countries. Amongst which 20% of the cancer lead to deaths in the European region.
Increasing focus on research to find a standard pertinent treatment is also expected to propel the radiodermatitis market. The lack of standard care products in the market makes it a highly opportune condition for players to set their innovative product ideas on the path of commercial success. Radiodermatitis is a skin condition which affects cancer patients undergoing radiation therapy or combination of chemotherapy and radiation therapy.
Rise in the number of people suffering from diabetes and obesity rapidly puts them at an added risk of developing cancer. This factor is likely to drive the need of the radiation therapy and boost the radiodermatitis incidences. Old age and obesity are also risk factors for cancer, which is likely to rise the demand of radiodermatitis drugs. According to the CDC’s (Centers for Disease Control), in year 2018, the diabetes cases have risen to 34.2 million, which is likely to grow to in the world by 2030. This escalation will indicate that there is a larger pool of patients likely to develop cancer and they would have a higher chance of radiation-induced skin damage due to co-morbid condition.
Product sales in the radiodermatitis market naturally tend to be higher in regions where the number of cancer patients undergoing radiation therapy is high. Asia Pacific leads the world in the number of cancer cases and in the number of patients undergoing combination of chemotherapy and radiation therapy, or radiation therapy by itself. The reach of a number of novel products developed in North America and Europe is gradually expanding in these regions as well as the Middle East & Africa via partnerships for distribution. This is likely to propel future demand for radiodermatitis care products.
View full report@ https://qyresearchmedical.com/report/radiodermatitis-market-product-type-topical-corticosteroids-hydrophilic-creams-and-antibiotics-oral-medication-corticosteroids-oral-analgesics-and-antibiotics-and-dressings-hydrogel-hydrocolloid-no-s-019-2030/111702
Higher Radiodermatitis Cost likely to Hamper Market
The burden of cost of cancer treatment is a concern in developing nations, where high cost of therapy leads to constraints in financial resources. Hence, high cost of products, especially dressings such as honey-impregnated dressings and silicone dressings, is likely to restrain the market. Moreover, availability of low cost locally-manufactured dressings in the emerging economies is expected to hamper the growth of branded and expensive dressings.
Moreover, In the United States, the treatment of Cancer drugs incurred expenses around US$100,000 and as per research, 63% of the cancer patients face financial crises during the course of the treatment. Thus, growing cost are likely to hamper the radiodermatitis market in coming years.
Global Radiodermatitis Market: Competitive Landscape
This report profiles major players in the global radiodermatitis market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. The global radiodermatitis market is fragmented, with the presence of a number of international, regional players as well as local players. Various players operating in the global radiodermatitis market are
- BMG Pharma
- ConvaTec Inc
- Integra Life Sciences
- Intermed Pharmaceuticals
- Molnlycke Health Care AB
- Smith & Nephew
- Stratpharma AG.
Global Radiodermatitis Market: Key Developments
Key players in the global radiodermatitis market are engaged in reimbursment scenarios, research & development, technological advancements, launch of new products, and acquisition & collaborative agreements with other companies. These strategies of key players are likely to fuel the growth of the global radiodermatitis market. A few expansion strategies adopted by players operating in the global radiodermatitis market are:
In April 2019, CIVCO Radiotherapy, expertise in offering high quality, patient centric radioactive solutions entered into collaboration with Stratpharma AG to expand their focus on wound care in radiation therapy patients. This is likely to focus on patient centric care and improve post procedure outcomes.
In July 2017, Stratpharma AG launched StrataXRT, the first and only topical film wound dressing product to manage radiation dermatitis. This product is innovative and flexible wound dressing product to promote rapid healing and post radiation therapy patients.
Expanding operations in future? To get the perfect launch ask for a custom report
The report on the global Radiodermatitis Market discussed individual strategies, followed by company profiles of manufacturers of drugs for managing Radiodermatitis condition. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global Radiodermatitis Market.
Key Questions Answered in Global Radiodermatitis Market Report
- What is the scope of growth of product companies in the global Radiodermatitis Market?
- What will be the Y-o-Y growth of the global Radiodermatitis Market between 2019 and 2027?
- What is the influence of growing disease prevalence on the global Radiodermatitis Market?
- What are the ongoing clinical trials/pipeline trend for the treatment of the Radiodermatitis condition?
- Which region continue to be the most profitable market for Radiodermatitis Market?
- Which factors are anticipated to hamper the growth of the global Radiodermatitis Market during the forecast period?
- Which are the leading companies in the global Radiodermatitis Market?
Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111702/2900
Global Radiodermatitis Market – Segmentation
- Hydrophilic Creams
- Topical Antibiotics
- Oral Medication
- Oral analgesics & Antibiotics
- No Sting Barrier Film
- Honey Impregnated gauze
- Silicone coated dressing
- Hospital Pharmacy
- Retail Pharmacy Store
- Online Store
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
TABLE OF CONTENT
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Radiodermatitis Market
4. Market Overview
4.1.1. Market Definition
4.1.2. Industry Evolution / Developments
4.3. Market Dynamics
4.4. Global Radiodermatitis Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Value Chain Analysis
5. Key Insights
5.1. Disease Provenance across Region/Globally
5.2. Pipeline Analysis
6. Global Radiodermatitis Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.1.1. Key Findings / Developments
6.2. Global Radiodermatitis Market Value Forecast, by Product , 2017–2027
22.214.171.124. Hydrophilic Creams
126.96.36.199. Topical Antibiotics
6.2.2. Oral Medication
188.8.131.52. Oral analgesics & Antibiotics
184.108.40.206. No sting Barrier film
220.127.116.11. Honey Impregnated gauze
18.104.22.168. Silicone coated dressing
6.3. Global Radiodermatitis Market Attractiveness, by Product
7. Global Radiodermatitis Market Analysis and Forecast, by Distribution Channel
7.1. Introduction & Definition
7.1.1. Key Findings / Developments
7.2. Global Radiodermatitis Market Value Forecast, by Distribution Channel , 2017–2027
7.2.1. Hospital Pharmacy
7.2.2. Retail Pharmacy Store
7.2.3. Online Store
7.3. Global Radiodermatitis Market Attractiveness, by Distribution Channel
8. Global Radiodermatitis Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Global Radiodermatitis Market Value Forecast, by Region
8.2.1. North America
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Global Radiodermatitis Market Attractiveness, by Region
9. North America Radiodermatitis Market Analysis and Forecast
9.1.1. Key Findings
9.2. North America Radiodermatitis Market Value (US$ Mn) Forecast, by Product , 2017–2027
22.214.171.124. Hydrophilic Creams
126.96.36.199. Topical Antibiotics
9.2.2. Oral Medication
188.8.131.52. Oral analgesics & Antibiotics
184.108.40.206. No sting Barrier film
220.127.116.11. Honey Impregnated gauze
18.104.22.168. Silicone coated dressing
9.3. North America Radiodermatitis Market Value (US$ Mn) Forecast, by Distribution Channel , 2017–2027
9.3.1. Hospital Pharmacy
9.3.2. Retail Pharmacy Store
9.3.3. Online Store
9.4. North America Radiodermatitis Market Value (US$ Mn) Forecast, by Country, 2017–2027
9.5. North America Radiodermatitis Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By Distribution Channel
9.5.3. By Country
10. Europe Radiodermatitis Market Analysis and Forecast
Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111702/2900
You can place an order or ask any questions, please feel free to contact email@example.com | +1 9197 992 333
QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.
For Latest Update Follow Us: